Shaanxi Meibang Pharmaceutical Group (605033.SH): The external circulation is relatively small and there is a risk of speculative trading in the secondary market.

Shaanxi Meibang Pharmaceutical Group (605033.SH) announced that the company's stock has experienced abnormal fluctuations in trading for two consecutive days on January 8th and 9th, 2025, with a cumulative deviation exceeding 20% in accordance with the relevant provisions of the Shanghai Stock Exchange Trading Rules. The company has advised that since January 2nd, 2025, the company's stock has reached trading limit for six consecutive days, with turnover rates of 2.5226%, 2.6101%, 13.6011%, 10.5012%, 5.1101%, and 4.9657% in the last six trading days, with trading amounts of 44.32 million, 51.27 million, 271 million, 241 million, 132 million, and 143 million respectively, indicating higher trading volume compared to previous levels. As of now, the company's controlling shareholder, actual controller, and concerted parties collectively hold 93,400,000 shares of the company, accounting for 69.08% of the total share capital, with the remaining being public float. With a small float in the market, there is a risk of irrational speculation in the secondary market. The company urges investors to pay attention to the risks of trading in the secondary market, make rational decisions, and invest cautiously.